Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50,300 KRW | -1.76% |
|
0.00% | -25.26% |
May. 28 | SK Chemicals Introduces Sustainable Packaging Solutions | MT |
May. 21 | SK Chemicals Implements Safety Evaluation System at Ulsan Plant | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.26% | 660M | |
-1.55% | 37.97B | |
-28.76% | 19.4B | |
-23.99% | 11.83B | |
-2.73% | 10.33B | |
-15.89% | 9.46B | |
+29.09% | 8.91B | |
-8.08% | 5.72B | |
-24.93% | 3.52B | |
-26.48% | 2.9B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.